TSLA

468.3

+2.53%↑

NKE

62.74

-2.86%↓

ORLY

91.68

-2.98%↓

68.13

-1.23%↓

AZO

3,571.63

-2.75%↓

TSLA

468.3

+2.53%↑

NKE

62.74

-2.86%↓

ORLY

91.68

-2.98%↓

68.13

-1.23%↓

AZO

3,571.63

-2.75%↓

TSLA

468.3

+2.53%↑

NKE

62.74

-2.86%↓

ORLY

91.68

-2.98%↓

68.13

-1.23%↓

AZO

3,571.63

-2.75%↓

TSLA

468.3

+2.53%↑

NKE

62.74

-2.86%↓

ORLY

91.68

-2.98%↓

68.13

-1.23%↓

AZO

3,571.63

-2.75%↓

TSLA

468.3

+2.53%↑

NKE

62.74

-2.86%↓

ORLY

91.68

-2.98%↓

68.13

-1.23%↓

AZO

3,571.63

-2.75%↓

Strona główna・Stock List・Medifast Inc

Medifast Inc

Closed

SectorConsumer cyclical

11.82 -1.25

Buy Sell

Overview

Share price change

24h

Current

Min

11.8

Max

12.14

Key metrics
By Trading Economics
Income	3.3M 2.5M
Sales	-10M 106M
P/E Sector Avg	38.576 30.703
Profit margin	2.349
Employees	504
EBITDA	961K 3M

Market Stats
By TradingEconomics
Market Cap	-17M 140M
Previous open	13.07
Previous close	11.82

News Sentiment

By Acuity

14%

86%

11 / 372 Ranking in Consumer cyclical

Technical Score

By Trading Central

Confidence

Bullish Evidence

12.35 / 12.98 Support & Resistance

Medifast Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

3 lis 2025, 21:44 UTC

Earnings

Vertex Pharmaceuticals Revenue Climbs on Demand for Cystic Fibrosis Drugs

3 lis 2025, 23:44 UTC

Market Talk

Nikkei May Rise on Weaker Yen, Hopes for Govt Econ Steps -- Market Talk

3 lis 2025, 23:34 UTC

Market Talk

Gold Edges Lower Amid Lingering Worry Over China's Ending of Tax Incentive -- Market Talk

3 lis 2025, 23:28 UTC

Earnings

Palantir Revenue Hits Another Record as Defense Work Booms -- 2nd Update

3 lis 2025, 23:24 UTC

Earnings

Correct: Grab Holdings Sees FY2025 Adj Ebitda $490M-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3 lis 2025, 23:14 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Global Equities Roundup: Market Talk

3 lis 2025, 23:14 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Deterra's Next CEO Might Bring New Approach to Deals -- Market Talk

3 lis 2025, 23:12 UTC

Earnings

Grab Holdings Sees FY2025 Adj Ebitda $490-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3 lis 2025, 23:09 UTC

Earnings

Grab Holdings 3Q 2Q Adj EBITDA $136.0M Vs. $90.0M>GRAB

3 lis 2025, 23:09 UTC

Earnings

Grab Holdings 3Q Net $17.0M Vs. Net $15.0M >GRAB

3 lis 2025, 23:09 UTC

Earnings

Grab Holdings 3Q Rev $873.0M Vs. $716.0M >GRAB

3 lis 2025, 23:06 UTC

Market Talk

Earnings

Palantir Execs Forecast Future of U.S. Workers In AI World -- Market Talk

3 lis 2025, 22:36 UTC

Market Talk

Earnings

Palantir's U.S. Commercial Business Booms as It Expands AI -- Market Talk

3 lis 2025, 22:31 UTC

Earnings

Franco-Nevada 3Q EPS $1.49 >FNV

3 lis 2025, 22:31 UTC

Earnings

Franco-Nevada 3Q Rev $487.7M >FNV

3 lis 2025, 22:24 UTC

Market Talk

Xero Bulls Expect Improving U.S. Momentum in 1H -- Market Talk

3 lis 2025, 22:19 UTC

Acquisitions, Mergers, Takeovers

Starbucks Agrees to Sell Stake in China Business -- WSJ

3 lis 2025, 21:59 UTC

Market Talk

RBA Set To Keep Rates On Hold; Remain Data Dependent -- Market Talk

3 lis 2025, 21:54 UTC

Market Talk

Earnings

Westpac's Tech Challenge Keeps Jefferies Cautious -- Market Talk

3 lis 2025, 21:54 UTC

Market Talk

Earnings

Global Equities Roundup: Market Talk

3 lis 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

3 lis 2025, 21:49 UTC

Earnings

Palantir Revenue Hits Another Record as Defense Work Booms -- Update

3 lis 2025, 21:40 UTC

Earnings

Barry Diller's IAC Inks AI Deal With Microsoft. That Isn't Why the Stock Is Sliding. -- Barrons.com

3 lis 2025, 21:31 UTC

Market Talk

Mexican Manufacturing Indexes Pick Up in October -- Market Talk

3 lis 2025, 21:19 UTC

Earnings

Palantir Revenue Hits Another Record as Defense Work Booms -- WSJ

3 lis 2025, 21:11 UTC

Acquisitions, Mergers, Takeovers

Pfizer Reports Earnings Tuesday. Management Has Big Questions to Answer. -- Barrons.com

3 lis 2025, 21:11 UTC

Earnings

Diamondback Energy: Increasing Full Yr Oil Production Guidance to 495-498 MBO/d and Increasing Annual BOE Guidance to 910-920 MBOE/d >FANG

3 lis 2025, 21:07 UTC

Earnings

Palantir Technologies: Raising 2025 U.S. Comml Rev Guidance to in Excess of $1.433B, Representing a Growth Rate of at Least 104% >PLTR

3 lis 2025, 21:05 UTC

Earnings

Vertex Pharmaceutic Sees 2025 Rev $11.9B-$12B >VRTX

3 lis 2025, 21:05 UTC

Earnings

Palantir Technologies 3Q Net $475.6M >PLTR

Peer Comparison

Price change

Medifast Inc Forecast

Rating Consensus

By TipRanks

0 ratings

Buy

Hold

Sell

Based on 0 analysts giving stock ratings to Medifast Inc - Dist in the past 3 months.

Technical Score

By Trading Central

12.35 / 12.98Support & Resistance

Bullish events outweigh bearish events.

All events are bearish.

There are no events.

Sentiment

By Acuity

11 / 372 Ranking in Consumer cyclical

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Medifast Inc

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States and the Asia-Pacific. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups, as well as provides coaching support along with community, nutrition, and healthy habits, and helps people in their weight loss journey. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.